Literature DB >> 29773020

Functions of IL-4 and Control of Its Expression.

Melissa A Brown1, John Hural1.   

Abstract

IL-4 has been called the "prototypic immunoregulatory cytokine." Like many cytokines, it can affect a variety of target cells in multiple ways. IL-4 has an important role in regulating antibody production, hematopoiesis and inflammation, and the development of effector T-cell responses. It is produced only by a subset of activated hematopoietic cells, including T cells and FcεRl+ mast cells and basophils. Based on the different tissue distribution and access to distinct target cells, IL-4 derived from T and FcεRl+ cells may have quite different effects on these immunological processes. In view of this, as well as the clear correlation of aberrant expression with disease, it is of interest to understand the signals that regulate IL-4 expression in a cell-specific manner. Recently, progress has been made in defining the T-cell- and FcεRl-receptor-mediated signals that stimulate IL-4 gene expression. These studies have demonstrated that there are common and cell-specific signaling pathways that regulate production of this cytokine. In this review, we summarize the activities of IL-4 defined both in vitro and in vivo and compare the signals leading to IL-4 expression in cells of both T- and mast-cell lineage.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29773020     DOI: 10.1615/CritRevImmunol.v37.i2-6.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  9 in total

Review 1.  Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.

Authors:  Patrizia Murer; Dario Neri
Journal:  N Biotechnol       Date:  2019-04-13       Impact factor: 5.079

2.  Impact of aging on gene expression response to x-ray irradiation using mouse blood.

Authors:  Constantinos G Broustas; Axel J Duval; Sally A Amundson
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

Review 3.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Authors:  Pio Conti; Luisa Stellin; Alesssandro Caraffa; Carla E Gallenga; Rhiannon Ross; Spyros K Kritas; Ilias Frydas; Ali Younes; Paolo Di Emidio; Gianpaolo Ronconi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

4.  Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function.

Authors:  Liliane Silvano Araújo; Marcos Vinícius da Silva; Crislaine Aparecida da Silva; Maria de Fátima Borges; Heloísa Marcelina da Cunha Palhares; Laura Penna Rocha; Rosana Rosa Miranda Corrêa; Virmondes Rodrigues Júnior; Marlene Antônia Dos Reis; Juliana Reis Machado
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

Review 5.  Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.

Authors:  Xujun Song; Benno Traub; Jingwei Shi; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

6.  The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study.

Authors:  Hanxiao Chen; Yaoyao Zhang; Shangwei Li; Yuanzhi Tao; Rui Gao; Wenming Xu; Yihong Yang; Kemin Cheng; Yan Wang; Lang Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-27       Impact factor: 5.555

7.  Effects of Casein Phosphopeptide-Selenium Complex on the Immune Functions in Beagle Dogs.

Authors:  Wencan Wang; Ling Xu; Yong Cao; Guo Liu; Qianru Lin; Xin Mao
Journal:  Animals (Basel)       Date:  2022-08-10       Impact factor: 3.231

8.  Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study.

Authors:  Jiram Torres-Ruiz; Julieta Lomelín-Gascón; Ana Sofía Vargas-Castro; Jaquelin Lira-Luna; Alfredo Pérez-Fragoso; Roberto Tapia-Conyer; Miroslava Nuñez-Aguirre; Beatriz Alcalá-Carmona; Abdiel Absalón-Aguilar; José Luis Maravillas-Montero; Nancy Raquel Mejía-Domínguez; Carlos Núñez-Álvarez; Marina Rull-Gabayet; Luis Llorente; Sandra Romero-Ramírez; Victor Andrés Sosa-Hernández; Rodrigo Cervantes-Díaz; Guillermo Juárez-Vega; David Eduardo Meza-Sánchez; Luis Alberto Martínez-Juárez; Linda Morales-Juárez; Lizeth Naomi López-López; José Adrián Negrete-Trujillo; Jorge Abelardo Falcón-Lezama; Rafael Ricardo Valdez-Vázquez; Héctor Gallardo-Rincón; Diana Gómez-Martín
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

9.  The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.

Authors:  Shilpa Ravindran; Saad Rasool; Cristina Maccalli
Journal:  Cancer Microenviron       Date:  2019-11-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.